No class action status in CA Vioxx lawsuit
Pharma Compliance Alert, May 13, 2009
Los Angeles Superior Court Judge Victoria G. Chaney denied class action status to plaintiffs seeking to sue Merck for its withdrawn painkiller Vioxx.
Chaney said in her ruling that trying plaintiffs’ claims would require an examination of each proposed class member’s medical needs and history, which Merck successfully argued would be unfair, according to a company statement.
Read more about Chaney's decision in the Vioxx lawsuit.
Related Products
Most Popular
- Articles
-
- Q/A: Billing telemetry daily monitoring
- Credentialing monthly: What is the role of the credentials committee in addressing unprofessional conduct?
- 2010 ICD-9 code updates now available online
- Master modifiers to ensure accurate reimbursement
- H1N1 hits Maine facility
- Radiologist indicted for fraudulently signing reports
- Don’t be scared into silence: Affiliation letter safeguards allow you to disclose more
- National Quality Forum creates standardized set of data for electronic health records
- New report reveals $47 billion in Medicare fraud
- Understand the H1N1 Flu and how to code it
- E-mailed
-
- Credentialing monthly: What is the role of the credentials committee in addressing unprofessional conduct?
- Q/A: Billing telemetry daily monitoring
- Radiologist indicted for fraudulently signing reports
- Revised MS.1.20 'huge improvement', out for comment again
- H1N1 hits Maine facility
- New report reveals $47 billion in Medicare fraud
- Briefings on Outpatient Rehab Reimbursement and Regulations, December 2009
- Hand hygiene rates improved through variety of reinforcement styles
- Press Ganey report: Patient satisfaction increasing across the country
- Residency Program Alert, December 2009
- Searched
